Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the Chinese State Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unres...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Xiao eMa (Autor), Ruisheng eLi (Autor), Jian eWang (Autor), Yinqiu eHuang (Autor), Pengyan eLi (Autor), Ji eWang (Autor), Haibin eSu (Autor), Ruilin eWang (Autor), Yaming eZhang (Autor), Honghong eLiu (Autor), Congen eZhang (Autor), Zhijie eMa (Autor), Jiabo eWang (Autor), Yanling eZhao (Autor), Xiaohe eXiao (Autor)
Format: Knjiga
Izdano: Frontiers Media S.A., 2016-03-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno